BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15375706)

  • 1. Chemoprevention of carcinogenesis in familial tumors.
    Ishikawa H
    Int J Clin Oncol; 2004 Aug; 9(4):299-303. PubMed ID: 15375706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention of carcinogenesis in familial tumors].
    Ishikawa H
    Gan To Kagaku Ryoho; 2005 Jul; 32(7):973-6. PubMed ID: 16044958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemoprevention of familial cancer].
    Ishikawa H
    Gan To Kagaku Ryoho; 1997 Jun; 24(8):951-7. PubMed ID: 9212803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of colorectal cancer.
    Das D; Arber N; Jankowski JA
    Digestion; 2007; 76(1):51-67. PubMed ID: 17947819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of suindac in the treatment of familial adenomatous polyposis coli].
    Landauer S; Halimi C; Caulin C; Bergmann JF
    Therapie; 1999; 54(6):675-82. PubMed ID: 10709439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of gastrointestinal cancer--the potential role of NSAIDs in colorectal cancer.
    Luk GD
    Schweiz Med Wochenschr; 1996 May; 126(19):801-12. PubMed ID: 8693304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of nonsteroidal anti-inflammatory drugs (NSAID) on colorectal polyps in patients with familial adenomatous polyposis: a review of clinical studies].
    Akasu T; Kakizoe T
    Nihon Geka Gakkai Zasshi; 1998 Jun; 99(6):385-90. PubMed ID: 9695077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemoprevention of colorectal cancer].
    Herszényi L; Juhász M; Prónai L; Tulassay Z
    Orv Hetil; 2004 Mar; 145(12):603-10. PubMed ID: 15119114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsteroidal anti-inflammatory drugs, COX-2 and colorectal cancer.
    Patrignani P
    Toxicol Lett; 2000 Mar; 112-113():493-8. PubMed ID: 10720771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
    Jacoby RF; Seibert K; Cole CE; Kelloff G; Lubet RA
    Cancer Res; 2000 Sep; 60(18):5040-4. PubMed ID: 11016626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of NSAIDs for the chemoprevention of colorectal cancer.
    Herendeen JM; Lindley C
    Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclo-oxygenase 2 inhibitors: emerging roles in the gut.
    Grover JK; Yadav S; Vats V; Joshi YK
    Int J Colorectal Dis; 2003 Jul; 18(4):279-91. PubMed ID: 12774242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase as a target for colorectal cancer chemoprevention.
    Moreira L; Castells A
    Curr Drug Targets; 2011 Dec; 12(13):1888-94. PubMed ID: 21158711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment with sulindac of adenomatous polyps in familial polyposis].
    Cerdán FJ; Torres-Melero J; Martínez S; Gutiérrez del Olmo A; Balibrea JL
    Rev Esp Enferm Dig; 1995 Aug; 87(8):574-6. PubMed ID: 7577106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase inhibition in cancer--a blind alley or a new therapeutic reality?
    Chau I; Cunningham D
    N Engl J Med; 2002 Apr; 346(14):1085-7. PubMed ID: 11932478
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemoprevention with special reference to inherited colorectal cancer.
    Lynch PM
    Fam Cancer; 2008; 7(1):59-64. PubMed ID: 17680350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
    Gill S; Sinicrope FA
    Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celecoxib: new indication. Colorectal cancer: no preventive benefit.
    Prescrire Int; 2006 Feb; 15(81):13-5. PubMed ID: 16548099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of human flavin monooxygenase 3 in sulindac-mediated primary chemoprevention of familial adenomatous polyposis.
    Hisamuddin IM; Wehbi MA; Chao A; Wyre HW; Hylind LM; Giardiello FM; Yang VW
    Clin Cancer Res; 2004 Dec; 10(24):8357-62. PubMed ID: 15623613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary chemoprevention of familial adenomatous polyposis with sulindac.
    Giardiello FM; Yang VW; Hylind LM; Krush AJ; Petersen GM; Trimbath JD; Piantadosi S; Garrett E; Geiman DE; Hubbard W; Offerhaus GJ; Hamilton SR
    N Engl J Med; 2002 Apr; 346(14):1054-9. PubMed ID: 11932472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.